severity
Pruritus cannot be measured directly and is difficult to quantify. 4, 5 Focus questions on impact on quality of life. May try questions using a rating scale: How severe is this symptom? What would you rate it on a scale of 0-10 (0 being none and 10 being the worst possible)? Right now? At worst? On average? How bothered are you by this symptom? Are there any other symptom(s) that accompany this symptom? (Existing itch measurement tools are too detailed and resource intensive for use in palliative care setting. 5 ) treatment What medications and treatments are you currently using? Are you using any non-prescription treatments, herbal remedies, or traditional healing practices? How effective are these? Do you have any side effects from the medications and treatments? What have you tried in the past? Do you have concerns about side effects or cost of treatments?
understanding What do you believe is causing this symptom? How is it affecting you and/or your family? What is most concerning to you?
Values
What overall goals do we need to keep in mind as we manage this symptom? What is your acceptable level for this symptom (0-10)? Are there any beliefs, views or feelings about this symptom that are important to you and your family?
symptom Assessment: Physical assessment as appropriate for symptom Diagnostics: consider goals of care before ordering diagnostic testing.
Step 3 | Determine possible causes and reverse as possible if in keeping with goals of care • Pruritus should not be considered simply a skin disorder, but rather a systemic problem for which there are multiple causes. It is difficult to isolate these entirely and some degree of overlap is likely. 6
• Systemic etiology may be present in 4-40% of all cases.6 Anxiety or fear may be both cause and consequence of pruritus.6
• Although it is normal to experience occasional mild or moderate pruritus, the severe pruritus seen in patients with advanced disease is usually associated with uremia (chronic renal failure), cholestasis, opioids, and hematologic disorders; it is a frequent complication of cholestasis.7 Solid tumours can cause pruritus via biliary obstruction (e.g., in pancreatic cancer). Dry skin also accompanies many of these conditions.8
PriNCiPLEs OF MANAGEMENt
When considering a management approach, always balance burden of a possible intervention against the likely benefit (e.g., does the intervention require transfer to another care setting?)
• There is no universally effective treatment for palliative care patients due to different pathomechanisms. 3, 9 • Combinations of systemic and topical agents often provide the best relief. 1
• Treatment evidence is stronger for systemic drug therapy than for topical therapy; however, topicals have fewer adverse effects.
• Treatment responses are very individual and cannot easily be predicted. 10 • Medications inducing photosensitivity may exacerbate itching; these include: NSAIDS, diuretics, antineoplastics, ciprofloxin. 11
• Address other associated cluster symptoms associated with pruritus including sleep, depression and pain.
• A multi-disciplinary team approach is often essential. 12, 13 Difficult cases require consultation with other medical specialists, e.g., palliative physician and dermatologist. 
Pruritus

Step 4 | Interventions
LEGEND FOr usE OF BuLLEts
Bullets are used to identify the type or strength of recommendation that is being made, based on a review of available evidence, using a modified GRADE process.
A Use with confidence: recommendations are supported by moderate to high levels of empirical evidence.
A Use if benefits outweigh potential harm: recommendations are supported by clinical practice experience, anecdotal, observational or case study evidence providing low level empirical evidence.
A Use with caution: Evidence for recommendations is conflicting or insufficient, requiring further study A Not recommended: high level empirical evidence of no benefit or potential harm
Non-pharmacological interventions
Interventions available in the home and residential care facilities
A tepid baths with mild, unscented soap can be soothing and temporarily relieve the itch. 1, 8 A Add baking soda to late evening bath to form protective layer and maintain hydration. 4, 7 A Dry skin by gently patting with soft towel or use hair dryer on low setting. 7 A use a "soak and seal" method: pat skin dry, lubricate the skin with a fragrance-A Provide cotton gloves for day or night use for those with strong urge to scratch. A Apply tap water wet dressings (e.g., cotton long underwear soaked in water) to the affected areas several times daily for 1-2 hours for excoriations and crusting due to scratching; provides temporary relief and hastens healing of injured skin. 1 A Loose, cotton clothing is less irritating, minimizes heat retention and sweating. 1 A Avoid fragrant topical agents, perfumes, perfumed soaps. 8 A Cool packs and loose, light cotton bedding. A Provide cool humidified environment. 2
Interventions requiring additional equipment or admission to acute care
A ultraviolet B light therapy performed 3 X a week may be useful in pruritus secondary to uremia, cholestasis and malignant skin infiltrations; may not be suitable for terminally ill persons. 8 stent placement helps pruritus from cholestasis secondary to pancreatic cancer (to decompress biliary obstruction )7,8,14 and might negate the need for any pharmacologic treatment, eliminating potential adverse side effects of certain drugs. 8 A Endoscopic or percutaneous biliary tree decompression should be considered in biliary obstruction. 15 
Pharmacological interventions (For more detailed pharmacological information, see Medications for management of pruritus)
High quality evidence for interventions in palliative care patients is lacking; the diverse nature and presentation of pruritus hamper studies and drug selection. 7, 9 A Antihistamines are generally not helpful, as the role of histamine remains unclear. 7, 8, 16 A Antihistamines value maybe limited to relief via sedation and use at bedtime. 4, 9 A Cetirizine is a very minimally sedating daytime antihistamine.
Pharmacological interventions continued on next page
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Non-pharmacological interventions continued
A Cholestyramine is the only drug with a Canadian licensed indication for treatment of pruritus, for use associated with partial biliary obstruction. 17 A Paroxetine's effectiveness is cautiously assumed for general palliative pruritus treatment, yet its harm assessment is limited. 3, 9 A Sertraline at low daily doses can be effective; does not require dose adjustment in renal impairment. Adverse effects may be minimal.
topicals
A Mild to moderate potency corticosteroids (for inflammation), topical anesthetics (lidocaine, prilocaine, pramoxine), doxepin. 2 A Cooling products such as menthol (0.25-2%), camphor (1-3%) are used within emollient compounds. 2 A Ketamine (0.5-5%) with amitriptyline (1-2%) in compounded creams. 18, 19 A Avoid topical antihistamine creams due to risk of allergic contact dermatitis. 7, 20 Other A Systemic corticosteroids have also been used for cholestatic pruritus. 21 A Case reports therapies have included: lidocaine infusion, 22 ranitidine, 23 and indomethacin for pruritus in HIV patients. 3
Patient and family education
A Prevent boredom or anxiety in creative, personalized ways. 7 A Avoid vasodilators such as coffee, alcohol, spices and hot water. A Teach recommended non-pharmacologic strategies. MANY drug interactions; assess risk prior to initiation.
Monitor liver function, particularly in first 2 months of treatment.
Do not drink alcohol while taking.
Take 1 hour before or 2 hours after a meal with a full glass of water.
To avoid long term adverse effects, (hepatitis, hemolytic anemia, renal failure, thrombocytopenia) stop if pruritus completely resolves. Sertraline (serotonin reduced via 5-HT3 receptor reduction) 2, 26, 29, 30 Cholestasis Initial: 25 mg PO daily.
Adjust by 25 mg per day every 4 to 5 days.
Maximum: 100 mg/day.
Adverse effects: insomnia, nausea.
Duration of antipruritic effect sustained throughout full treatment use, unlike paroxetine.
Use caution in seizure disorder patients.
No adjustment needed in renal impairment. † Off-label. PO = by mouth IV = Intravenous, SC = Subcutaneous, TID = three times daily, QID = four times daily ODT = oral dissolving tablet CSCI = continuous subcutaneous infusion.
Prices for prescription drugs may be obtained from BC PharmaCare. The British Columbia Palliative Care Benefits Plan http://www2.gov.bc.ca/assets/gov/health/health-drugcoverage/pharmacare/palliative-formulary.pdf provides province wide drug coverage for many of the recommended medications-check website to confirm coverage. Consider price when choosing similarly beneficial medications, especially when the patient / family is covering the cost.
